These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 29807998)
1. Did two booster doses for schoolchildren change the epidemiology of pertussis in Israel? Anis E; Moerman L; Ginsberg G; Karakis I; Slater PE; Warshavsky B; Gosinov R; Grotto I; Marva E J Public Health Policy; 2018 Aug; 39(3):304-317. PubMed ID: 29807998 [TBL] [Abstract][Full Text] [Related]
2. The impact of additional pertussis vaccine doses on disease incidence in children and infants. Stein-Zamir C; Shoob H; Abramson N; Zentner G Vaccine; 2010 Dec; 29(2):207-11. PubMed ID: 21055497 [TBL] [Abstract][Full Text] [Related]
3. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Lavine JS; Bjørnstad ON; de Blasio BF; Storsaeter J Vaccine; 2012 Jan; 30(3):544-51. PubMed ID: 22119924 [TBL] [Abstract][Full Text] [Related]
4. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. de Greeff SC; Mooi FR; Schellekens JF; de Melker HE Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of routine and booster pertussis vaccination in children and adolescents, federal state of Brandenburg, Germany, 2002-2012. Haller S; Dehnert M; Karagiannis I; Rieck T; Siffczyk C; Wichmann O; Poethko-Mueller C; Hellenbrand W Pediatr Infect Dis J; 2015 May; 34(5):513-9. PubMed ID: 25621762 [TBL] [Abstract][Full Text] [Related]
6. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365 [TBL] [Abstract][Full Text] [Related]
7. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Forsyth K; Nagai M; Lepetic A; Trindade E Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S93-7. PubMed ID: 15876935 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Gustafsson L; Hessel L; Storsaeter J; Olin P Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988 [TBL] [Abstract][Full Text] [Related]
9. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand. Radke S; Petousis-Harris H; Watson D; Gentles D; Turner N Vaccine; 2017 Jan; 35(1):177-183. PubMed ID: 27866766 [TBL] [Abstract][Full Text] [Related]
10. Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada. Brousseau N; Skowronski DM; Bellemare D; Amini R; Joffres Y; Clarke Q; Quach C; Rallu F; Hoang L; De Serres G Vaccine; 2020 Jan; 38(3):427-432. PubMed ID: 31685295 [TBL] [Abstract][Full Text] [Related]
11. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children. Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504 [TBL] [Abstract][Full Text] [Related]
12. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil. Luz PM; Codeço CT; Werneck GL; Struchiner CJ Epidemiol Infect; 2006 Aug; 134(4):850-62. PubMed ID: 16316489 [TBL] [Abstract][Full Text] [Related]
13. Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998-2019. Seppälä E; Bråthen Kristoffersen A; Bøås H; Frimann Vestrheim D; Greve-Isdahl M; Freiesleben De Blasio B; Steens A Vaccine; 2022 May; 40(23):3142-3149. PubMed ID: 35469697 [TBL] [Abstract][Full Text] [Related]
14. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria. Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375 [TBL] [Abstract][Full Text] [Related]
15. The re-emergence of pertussis in Israel. Moerman L; Leventhal A; Slater PE; Anis E; Yishai R; Marva E Isr Med Assoc J; 2006 May; 8(5):308-11. PubMed ID: 16805226 [TBL] [Abstract][Full Text] [Related]
16. Pertussis before and after the introduction of acellular pertussis vaccines in Finland. Elomaa A; He Q; Minh NN; Mertsola J Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060 [TBL] [Abstract][Full Text] [Related]
17. Whooping cough, twenty years from acellular vaccines introduction. Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of pertussis booster vaccination in the Netherlands. Rozenbaum MH; De Cao E; Postma MJ Vaccine; 2012 Nov; 30(50):7327-31. PubMed ID: 22749838 [TBL] [Abstract][Full Text] [Related]
19. [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003]. de Greeff SC; Schellekens JF; Mooi FR; de Melker HE Ned Tijdschr Geneeskd; 2005 Apr; 149(17):937-43. PubMed ID: 15884408 [TBL] [Abstract][Full Text] [Related]
20. [Time for booster doses against whooping cough for 10-year-old children]. Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]